Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Filgrastim × Breast × Clear all

Phase

Phase 2 32 Phase 3 13 Phase 1 12 Phase 1/2 11 Phase 4 6 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 17 Other hematologic neoplasm 16 Myeloid 7 Plasma cell 6 Dermatologic 6 Sarcoma 5 Classical hematology 2 Head & Neck 1 Genitourinary 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Exercise 103 Surveys and Questionnaires 50 Magnetic Resonance Spectroscopy 47 Educational Status 45 Early Intervention, Educational 44 Methods 43 Acupuncture Therapy 43 Standard of Care 42 Blood Specimen Collection 38 Radiotherapy 37 Mammography 37 Control Groups 33 Counseling 28 Sentinel Lymph Node Biopsy 25 Psychiatric Rehabilitation 24 Therapeutics 23 Cyclophosphamide 23 Yoga 22 Practice Guidelines as Topic 21 Biopsy 20 Palliative Care 18 Resistance Training 17 Mastectomy, Segmental 17 Interviews as Topic 17 Neoadjuvant Therapy 16 High-Energy Shock Waves 16 Surgical Procedures, Operative 15 Radiosurgery 15 Magnetic Resonance Imaging 15 Cognitive Behavioral Therapy 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05296317 2026-02-19

EMEG-ECDD

Centre Georges Francois Leclerc

Phase NA Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡